• Search

    Long-term API stockpiling and rapid finished dose form manufacture

    Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency

    Long-term API stockpiling and rapid finished dose form manufacture

    1. Competition notice published

      Jun 22, 5:41 AMJune 22, 2026 5:41 AM

    2. Questions deadline

      Sep 21, 9:59 PMSeptember 21, 2026 9:59 PM

    3. Tender submission deadline

      Sep 29, 1:00 PMSeptember 29, 2026 1:00 PM

    4. Opening date

      Sep 30, 8:00 AMSeptember 30, 2026 8:00 AM

    5. Tender validity period

      Mar 29, 1:00 PMMarch 29, 2027 1:00 PM

    Brief

    Tender search/Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency/Long-term API stockpiling and rapid finished dose form manufacture
    Brief

    Forsknings- og utviklingsvirksomhet og tilhørende konsulenttjenester

    The Health and Digital Executive Agency (HaDEA) needs services for a feasibility project on "Long-term API stockpiling and rapid finished dose form manufacture" over 3 years, with a maximum total value of 6,000,000 EUR. This project aims to support the development of and access to technologies that can prolong the shelf-life of Active Pharmaceutical Ingredients (APIs) stored in bulk and advanced manufacturing technologies to produce finished dose forms from those bulk APIs rapidly, enhancing crisis preparedness by exploring potential gains in sustainability, resiliency, and flexibility to respond to future health emergencies. The upcoming call for tenders will request the development of a pilot feasibility project to test this concept, assess its viability, and provide recommendations on how to operationalise the approach. Award criteria will be based on quality (80%) and price (20%).

    About the bid

      The European Health and Digital Executive Agency (HaDEA) is planning to launch a call for tenders on "Long-term API stockpiling and rapid finished dose form manufacture", a feasibility project to assess its application in crisis preparedness. This project aims to support the development of and access to technologies that can prolong the shelf-life of Active Pharmaceutical Ingredients (APIs) stored in bulk and advanced manufacturing technologies to produce finished dose forms from those bulk APIs rapidly, enhancing crisis preparedness by exploring potential gains in sustainability, resiliency, and flexibility to respond to future health emergencies. The upcoming call for tenders will request the development of a pilot feasibility project to test this concept, assess its viability, and provide recommendations on how to operationalise the approach.

      Contact phone
      +32 2 299 11 11
      Contact email
      hadea-procurement@ec.europa.eu
      Address
      COV2, Place Charles Rogier 16, B-1210 Brussels

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

    • Description

      Please consult the procurement documents.

    • Description

      Please consult the procurement documents.

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency
    Title
    Long-term API stockpiling and rapid finished dose form manufacture
    Type
    CompetitionPrequalification
    Main code
    73100000Research and experimental development services
    Supplemental codes

    No supplemental codes from buyer…

    Estimated value
    €6,000,000.00
    Duration
    36 months

    Active similar competitions

    • Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency

      Dekk og biltilbehør

      Capacity Reservation for Personal Protective Equipment Pilot

      The Health and Digital Executive Agency (HaDEA) in Belgium needs services for the reservation of manufacturing capacity and contractor-managed stockpiles of nitrile examination gloves (lot 1) and FFP2 respiratory masks (lot 2) for a duration of 3 years, with a maximum total value of 34,000,000 EUR. The purpose is to enhance the accessibility and availability of Medical Counter-Measures (MCMs) in the EU/EEA, with the contractor required to have manufacturing capacity within the EU/EEA. The contracting authority and/or the European Commission will have the right to purchase the stockpiled or manufactured MCMs for preparedness or crisis purposes. Each lot will be awarded to a maximum of three tenderers. Award criteria are Quality (60%) and Price (40%).

      CompetitionJul 20, 2026
      Oct 15, 2026(22 days)
      €34,000,000

    • Assistance publique des hôpitaux de Paris (AP-HP)

      Farmasøytisk engroshandel

      Marché visant l’achat de matières premières à usage pharmaceutique, le développement, la fabrication, les prestations associées, et l’importation de médicaments pour le compte de l’Établissement pharmaceutique (EP) de l’AP-HP ainsi que, le cas échéant, la distribution pharmaceutique réalisée par le fabricant ou l’opérateur admis dans le marché, dans le cadre de la feuille de route du médicament (

      L'AGEPS DAEF a besoin de produits pharmaceutiques pour une durée de 12 ans. Le marché vise l'achat de matières premières à usage pharmaceutique, le développement, la fabrication, les prestations associées et l'importation de médicaments pour le compte de l'Établissement pharmaceutique (EP) de l'AP-HP, ainsi que, le cas échéant, la distribution pharmaceutique réalisée par le fabricant ou l'opérateur admis dans le marché, dans le cadre de la feuille de route du médicament.

      Dynamic purchasing systemFeb 10, 2026
      Feb 15, 2038(100+ days)

    • European Union Drugs Agency

      Forskning og miljøovervåking

      MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration

      The European Union Drugs Agency (EUDA) needs services for a "MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration" contract over 3 years, with a maximum total value of 500,000 EUR. The objective is to reinforce collective capacity across the EU to interpret toxicological findings and improve the detection, identification, and timely reporting of exposure to New Psychoactive Substances (NPS) and other illicit drugs by generating robust metabolic, pharmacological, and analytical data and consolidating these into a centralised, accessible EU database. The contract will be awarded based on quality and price.

      CompetitionSep 21, 2026
      Oct 14, 2026(21 days)
      €500,000

    • European Centre for Disease Prevention and Control

      Helse- og sosial tjenesteyting

      OHD/260917 - Scientific and technical support to antimicrobial resistance surveillance

      The European Centre for Disease Prevention and Control needs services for scientific and technical support to the development and coordination of EARS-Net and related antimicrobial resistance (AMR) activities, and to provide scientific and technical advice needed to conduct state-of-the-art analysis of AMR data. This is a framework agreement for 4 years with a maximum total value of 288,000 EUR. Offers will be evaluated based on quality (60%) and price (40%).

      Framework agreementSep 17, 2026
      Oct 26, 2026(33 days)
      €288,000

    • European Medicines Agency, MED - European Medicines Agency

      Call for expression of interest for medical device and in-vitro diagnostics medical devices experts (EXPAMED) and patient, consumer and healthcare professional experts (P&HCP)

      Call for expression of interest for medical device experts (EXPAMED) and Patients Consumer and Healthcare professional experts.

      CompetitionAug 29, 2024
      Aug 28, 2029(100+ days)